ReposiTrak (TRAK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for November 19, 2025, at the company’s Utah headquarters, with shareholders invited to vote on key proposals and access materials online to conserve resources.
Proposals include electing four directors, advisory votes on executive compensation and its frequency, and ratification of the external auditor.
Shareholders of record as of September 26, 2025, are eligible to vote, with both common and Series B Preferred stockholders entitled to participate.
The Board unanimously recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Four director nominees are up for election for one-year terms expiring at the 2026 annual meeting.
Advisory votes will be held on executive compensation (Say-on-Pay) and the frequency of future Say-on-Pay votes, with the Board recommending a three-year interval.
Ratification of Haynie & Company as the independent registered public accounting firm for fiscal year ending June 30, 2026, is proposed.
Shareholders may submit proposals for the 2026 meeting, subject to compliance with SEC and bylaw requirements.
Board of directors and corporate governance
The Board consists of four directors, three of whom are independent under NYSE and SEC rules.
Director nominees include Randall K. Fields (Chairman/CEO), Robert W. Allen, Ronald C. Hodge, and Peter J. Larkin, each bringing significant industry and executive experience.
Committees include Audit, Compensation, and Nominating and Corporate Governance, all composed of independent directors.
The Board holds regular executive sessions without management and encourages direct shareholder communication.
Latest events from ReposiTrak
- Q2 revenue up 7%, EPS up 13%, strong cash, no debt, and leadership in traceability.TRAK
Q2 202617 Feb 2026 - Record revenue, net income, and cash with accelerating traceability and higher dividends.TRAK
Q4 202420 Jan 2026 - Traceability and retailer mandates drove 8% revenue growth and a 10% dividend increase.TRAK
Q1 202513 Jan 2026 - Deferred revenue up 70% and double-digit growth expected, fueled by traceability demand.TRAK
Q2 202523 Dec 2025 - Director elections, auditor ratification, and executive pay aligned with performance highlight the meeting.TRAK
Proxy Filing1 Dec 2025 - Preliminary proxy statement filed, detailing voting matters and shareholder procedures.TRAK
Proxy Filing1 Dec 2025 - Preliminary proxy outlines voting items and governance for the upcoming shareholder meeting.TRAK
Proxy Filing1 Dec 2025 - Q3 revenue up 16% and net income up 27%, with strong recurring revenue and cash flow.TRAK
Q3 202526 Nov 2025 - Double-digit revenue growth, higher net income, and increased dividends highlight strong performance.TRAK
Q1 202617 Nov 2025